Thompson L, Ferguson A, Raheel H, Lovvorn A, Hengstermann-Artiga M, Lopez M
PLoS One. 2025; 19(12):e0316161.
PMID: 39775435
PMC: 11684596.
DOI: 10.1371/journal.pone.0316161.
Nicholls S, Carroll K, Hey S, Zwarenstein M, Zhang J, Nix H
J Clin Epidemiol. 2021; 137:45-57.
PMID: 33789151
PMC: 8996736.
DOI: 10.1016/j.jclinepi.2021.03.021.
Pawson R
BMC Med Res Methodol. 2019; 19(1):176.
PMID: 31420024
PMC: 6698004.
DOI: 10.1186/s12874-019-0814-9.
Nicholls S, Carroll K, Brehaut J, Weijer C, Hey S, Goldstein C
BMC Med Ethics. 2018; 19(1):90.
PMID: 30458809
PMC: 6247737.
DOI: 10.1186/s12910-018-0332-z.
Yang W, McNutt T, Dudley S, Kumar R, Starmer H, Gourin C
Dysphagia. 2016; 31(2):206-13.
PMID: 26753929
DOI: 10.1007/s00455-015-9679-1.
A process for Decision-making after Pilot and feasibility Trials (ADePT): development following a feasibility study of a complex intervention for pelvic organ prolapse.
Bugge C, Williams B, Hagen S, Logan J, Glazener C, Pringle S
Trials. 2013; 14:353.
PMID: 24160371
PMC: 3819659.
DOI: 10.1186/1745-6215-14-353.
Are explanatory trials ethical? Shifting the burden of justification in clinical trial design.
Borgerson K
Theor Med Bioeth. 2013; 34(4):293-308.
PMID: 23812957
DOI: 10.1007/s11017-013-9262-4.
The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team.
Riddle D, Johnson R, Jensen M, Keefe F, Kroenke K, Bair M
J Clin Epidemiol. 2010; 63(11):1271-5.
PMID: 20670911
PMC: 2943562.
DOI: 10.1016/j.jclinepi.2010.03.006.
Making trials matter: pragmatic and explanatory trials and the problem of applicability.
Treweek S, Zwarenstein M
Trials. 2009; 10:37.
PMID: 19493350
PMC: 2700087.
DOI: 10.1186/1745-6215-10-37.
What kind of randomized trials do we need?.
Zwarenstein M, Treweek S
CMAJ. 2009; 180(10):998-1000.
PMID: 19372438
PMC: 2679816.
DOI: 10.1503/cmaj.082007.
